Invitation to submit to special issues of the Journal of Neuromuscular Diseases

The Journal of Neuromuscular Diseases has two exciting special issues that are open for submission of NMD research papers. One is a special issue dedicated to sharing unexpected or ‘negative’ data, and the other is a celebration of Prof. Terence Partridge’s career in the field of myogenesis and skeletal muscle diseases.  Details are provided below and more information can be found on the journal website accessible here. We welcome all submissions for these special issues, as well as other research with a neuromuscular theme.

As a further new outreach strategy, the journal is also inviting authors to share the story behind their research in the form of videos or animations that will be publicised via social media. We look forward to seeing the results of this project!

*Hanns is joint editor-in-chief of the Journal of Neuromuscular Diseases, together with Carsten Bönnemann of the NIH National Institute of Neurological Disorders and Stroke.

Visit the JND website here.

JND Call for Papers #1: The Null Hypothesis Special Issue

Special issue dedicated to studies where the results do not support the intervention tested and yet generate very useful data for the field. Testing if a hypotheses is correct or not is the way science advances, but pressure to publish has resulted in researchers preferentially publishing studies that disprove the null hypothesis. Failure to publish studies where, for example, therapies did not have beneficial effects, not only impedes science and therapy development, it also leads to unnecessary duplication of efforts and a waste of resources.

This issue is guest edited by Annemieke Aartsma-Rus and Virginia Arechavala-Gomeza and submissions are due by March 2021.

JND Call for Papers #2: Terence Partridge Special Issue

This issue will celebrate the distinguished career of Prof. Terence Partridge, with submissions forming a tribute to his significant contributions to the field of muscle biology through his own discoveries and production of exceptional trainees. If you have been affiliated with Prof. Partridge and would like to participate in this special issue, check out the information on the JND website and contact the guest editors via the editorial office.

This issue is guest edited by Jyoti Jaiswal and Kanneboyina Nagaraju and the publication date will be summer 2021.

JND_logo

Read next...

We are hiring a new clinical research coordinator!

Lochmüller Research Group Hiring Clinical Trial Coordinator

Due to recent funding success and expansion of our clinical trials team we have a need for a highly motivated Research Coordinator that will assist...
First participant screened in global CMS natural history study

The Ottawa Neuromuscular Centre screens first participant in the world for a multinational congenital myasthenic syndrome natural history study

The neuromuscular centre at The Ottawa Hospital is excited to announce that we are the first site globally to screen a participant for the multinational...
Copy of Lochmuller Lab - PhD opportunity (LLab)

Lochmüller Lab seeking PhD student

The Lochmüller Research Group are seeking a highly motivated PhD student to join our team at the Childrens Hospital of Eastern Ontario Research Institute (CHEO...
New Publication - Leading global expert in DMD and bone health Dr. Leanne Ward publishes systematic review and grading of evidence for biphosphonate therapy in glucocorticoid-treated patients with Duchenne Muscular Dystrophy in Neurology, with Dr. Hanns Lochmüller as a co-author.

New Publication: Bisphosphonates in Glucocorticoid-Treated Patients with Duchenne Muscular Dystrophy: A Systematic Review and Grading of the Evidence

Leading global expert in Duchenne Muscular Dystrophy (DMD) and bone health Dr. Leanne Ward publishes systematic review and grading of evidence for bisphosphonate therapy in...
text reding new clinical trial opportunities

New Clinical Trial Opportunities for Children and Adults in Ottawa

Our clinical research team is excited to share five new clinical trials activated across both pediatric and adult sites in Ottawa, CHEO and TOH. We...
Dr. Andreas Roos receiving award on WMS 2023 stage, with text reading Congratulaions Dr. Andreas Roos, WMS President's Prize for Emerging Myologist of the Year 2023.

Dr. Andreas Roos wins Emerging Myologist of the Year Prize at WMS 2023

We are excited to congratulate Dr. Andreas Roos on winning the World Muscle Society’s (WMS) President’s Prize for Emerging Myologist of the Year!   This award...